ClinicalTrials.Veeva

Menu

Can a Pulmonologist Reliably Assess the Tumor Burden on ROSE Slides Obtained From Pulmonary Nodules and Lymphadenopathy

M

Maggiore Bellaria Hospital, Bologna

Status

Completed

Conditions

Lung Cancer

Treatments

Diagnostic Test: Rapid on-site evaluation

Study type

Observational

Funder types

Other

Identifiers

NCT03845764
Bio-Pulmo-ROSE

Details and patient eligibility

About

The study is aimed at verifying if a pulmonologist can reliably assess the tumor burden for the extractive molecular analysis in ROSE samples obtained with endoscopic sampling procedures from intrathoracic lymphadenopathy and pulmonary nodules.

Enrollment

164 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • Indication for endoscopic sampling of suspected malignant lymphadenopathy or pulmonary lesion
  • Written informed consent

Exclusion criteria

  • High risk conditions for the performance of bronchoscopy and/or EBUS-TBNA
  • High risk condition for deep sedation (ASA 4)
  • Pregnancy

Trial design

164 participants in 1 patient group

Rapid on-site evaluation (ROSE)
Description:
Evaluation, made by a pulmonologist, a pathologist and a molecular pathologist, of the tumor burden in ROSE slides produced from endoscopic procedures aimed at sampling intrathoracic lymphadenopathy and pulmonary nodules
Treatment:
Diagnostic Test: Rapid on-site evaluation

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems